Showing 2501-2520 of 7110 for: Cochrane Systematic Reviews Back
- Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction
Cochrane Systematic Reviews, 6-Nov-2015
Gonadotrophin-releasing hormone agonists (GnRHa) are commonly used in assisted reproduction technology (ART) cycles to prevent a luteinising hormone surge during controlled ovarian hyperstimulation (COH) prior to planned oocyte retrieval, thus optimising
- Gonadotrophin-releasing hormone analogue as an adjunct to gonadotropin therapy for clomiphene-resistant polycystic ovarian syndrome
Cochrane Systematic Reviews, 17-Jul-2008
Elevation of endogenous LH levels may result in premature luteinization. This may also be associated with the increased rate of spontaneous abortion. Gonadotropin releasing hormone analogue (GnRHa) used prior to human menopausal gonadotropin (hMG/FSH) adm
- Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density
Cochrane Systematic Reviews, 20-Sep-2010
Gonadotrophin-releasing hormone analogues (GnRHas) are generally well tolerated, and are effective in relieving the symptoms of endometriosis (Prentice 2003). Unfortunately the low oestrogen state that they induce is associated with adverse effects includ
- Gonadotrophin-releasing hormone analogues for pain associated with endometriosis
Cochrane Systematic Reviews, 16-Mar-2010
Endometriosis is a common gynaecological condition that frequently presents with the symptom of pain. The precise pathogenesis (mode of development) of endometriosis is unclear but it is evident that endometriosis arises by the dissemination of endometriu
- Gonadotrophin-releasing hormone analogues for pain associated with endometriosis
Cochrane Systematic Reviews, 1-Nov-2010
Endometriosis is a common gynaecological condition, characterised by the presence of endometrial tissue in sites other than the uterine cavity (excluding adenomyosis) that frequently presents with pain. The gonadotrophin-releasing hormone analogues (GnRHa
- Gonadotrophin-releasing hormone antagonists for assisted reproductive technology
Cochrane Systematic Reviews, 5-Jul-2011
Gonadotrophin-releasing hormone (GnRH) antagonists can be used to prevent a luteinizing hormone (LH) surge during controlled ovarian hyperstimulation (COH) without the hypo-estrogenic side-effects, flare-up, or long down-regulation period associated with
- Gonadotrophins for idiopathic male factor subfertility
Cochrane Systematic Reviews, 18-Aug-2013
Male factors leading to subfertility account for at least half of all cases of subfertility worldwide. Although some causes of male subfertility are treatable, treatment of idiopathic male factor subfertility remains empirical. Researchers have used gonad
- Gonadotrophins for ovulation induction in women with polycystic ovarian syndrome
Cochrane Systematic Reviews, 28-Aug-2015
Ovulation induction with follicle stimulating hormone (FSH) is the second-line treatment in women with polycystic ovary syndrome (PCOS) who do not ovulate or conceive on clomiphene citrate (CC).
- Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology
Cochrane Systematic Reviews, 31-Oct-2014
Human chorionic gonadotropin (HCG) is routinely used for final oocyte maturation triggering in in vitro fertilisation (IVF)/intracytoplasmic sperm injection (ICSI) cycles, but the use of HCG for this purpose may have drawbacks. Gonadotropin-releasing horm
- Gowning by attendants and visitors in newborn nurseries for prevention of neonatal morbidity and mortality
Cochrane Systematic Reviews, 22-Apr-2003
Overgowns are widely used in newborn nurseries and neonatal intensive care units. It is thought that gowns may help to prevent the spread of nosocomial infection and serve as a reminder to staff and visitors to wash their hands before contact with the inf
- Gradual versus abrupt discontinuation of oxygen in preterm or low birth weight infants
Cochrane Systematic Reviews, 10-Nov-2008
The issue of whether to abruptly or gradually discontinue supplemental oxygen is a contentious one. There have been mixed results in studies of both humans and animal models on the effects of either method of oxygen cessation on important infant outcomes.
- Graduated compression stockings for prevention of deep vein thrombosis
Cochrane Systematic Reviews, 24-Nov-2015
One of the settings where deep vein thrombosis (DVT) in the lower limb and pelvic veins occurs is in hospital with prolonged immobilisation of patients for various surgical and medical illnesses. Using graduated compression stockings (GCS) in these patien
- Graduated compression stockings for the initial treatment of varicose veins in people without venous ulceration
Cochrane Systematic Reviews, 16-Jul-2021
Compression hosiery or stockings are often the first line of treatment for varicose veins in people without either healed or active venous ulceration. Evidence is required to determine whether the use of compression stockings can effectively manage and tr
- Graduated driver licensing for reducing motor vehicle crashes among young drivers
Cochrane Systematic Reviews, 30-Aug-2011
Graduated driver licensing (GDL) has been proposed as a means of reducing crash rates among novice drivers by gradually introducing them to higher risk driving situations.
- Graft type for femoro‐popliteal bypass surgery
Cochrane Systematic Reviews, 11-Feb-2018
Femoro-popliteal bypass is implemented to save limbs that might otherwise require amputation, in patients with ischaemic rest pain or tissue loss; and to improve walking distance in patients with severe life-limiting claudication. Contemporary practice in
- Granulocyte and granulocyte-macrophage colony stimulating factors for newly diagnosed patients with myelodysplastic syndromes
Cochrane Systematic Reviews, 12-Feb-2016
Myelodysplastic syndromes (MDS) are a heterogeneous group of haematological diseases which are characterised by a uni- or multilineage dysplasia of haematological stem cells. Standard treatment is supportive care of the arising symptoms including red bloo
- Granulocyte colony stimulating factor therapy for acute myocardial infarction
Cochrane Systematic Reviews, 31-May-2013
Acute myocardial infarction (AMI) is the leading cause of death in developed countries, and current treatment modalities have failed to regenerate the dead myocardium resulting from the ischemic damage. Stem cells have the potential to regenerate the dama
- Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropenia
Cochrane Systematic Reviews, 28-Aug-2011
Neonates have immature granulopoiesis, which frequently results in neutropenia after sepsis. Neutropaenic septic neonates have a higher mortality than non-neutropenic septic neonates. Therefore, granulocyte transfusion to septic neutropenic neonates may i
- Granulocyte transfusions for preventing infections in people with neutropenia or neutrophil dysfunction
Cochrane Systematic Reviews, 25-Jun-2015
Despite modern antimicrobials and supportive therapy, bacterial and fungal infections are still major complications in people with prolonged disease-related or therapy-related neutropenia. Since the late 1990s there has been increasing demand for donated
- Granulocyte transfusions for treating infections in patients with neutropenia or neutrophil dysfunction
Cochrane Systematic Reviews, 5-Jul-2010
Transfusions of granulocytes have a long history of usage in clinical practice to support and treat severe infection in high risk groups of patients with neutropenia or neutrophil dysfunction. However, there is considerable current variability in therapeu
